1365267-27-1 Ensartinib

Pwopriyete

Aparans blan nan poud blan-blan
Pwen bouyi: 695.1 ± 55. 0 degre
Dansite 1.428 ± 0. 06 g\/cm3
Depo tanperati. Magazen nan -20 degre
 

Aplikasyon:

Ensartinib se sitou itilize nan trete ALK pozitif ki pa Peye-ti kansè nan poumon selil (NSCLC), espesyalman nan pasyan ki te pwogrese oswa vin entolerans apre tretman anvan ak crizotinib. Ensartinib se yon ti molekil oral tirozin kinaz inibitè ki ka espesyalman anpeche aktivite a nan ALK (anaplastic lenfom kinaz), kidonk bloke kwasans lan ak divizyon siyal nan selil timè
 

Sinonim:

1365267-27-1

X-376

(R) -6- amino -5- (1- (2, 6- dichloro -3- fluorophenyl) ethoxy) -n-({{8 }} (4- methylpiperazine -1- carbonyl) fenil) piridazin -3- carboxamide

6- amino -5- [(1r) -1- (2, 6- dichloro -3- fluorophenyl) ethoxy] -n-[{{9 }} (4- methylpiperazine -1- carbonyl) phenyl] piridazine -3- carboxamide

3- piridazinecarboxamide, 6- amino -5- ((1r) -1- (2, 6- dichloro -3- fluorophenyl) eth oxy) -n-(4- ((4- methyl -1- piperazinyl) carbonyl) fenil)-

X -376 (estanda)

Baj popilè: 1365267-27-1 Ensartinib, Lachin 1365267-27-1 Ensartinib Konpayi fabrikasyon, Swèd